BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2214181)

  • 21. [Clinical studies of natural interferon alpha (HLBI) in chronic myelogenous leukemia--a multi-institutional cooperative study in Japan].
    Koyama S; Moriyama Y; Shibata A; Miura Y; Abe T; Asano S; Miyazaki T; Miura A; Kariyone S; Toyama K
    Gan To Kagaku Ryoho; 1988 Oct; 15(10):2959-66. PubMed ID: 3052301
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Successful one antigen mismatched bone marrow transplant for chronic myeloid leukemia (CML) after two failed syngeneic transplants.
    Manna A; Bacigalupo A; Palazzo G; Amurri B; Maggi A; Mazza P
    Bone Marrow Transplant; 1999 May; 23(10):1085-6. PubMed ID: 10373077
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A case of chronic myeloid leukemia with cytogenetic remission and disappearance of Ph1 positive cells due to interferon-alpha administration].
    Yoshida M; Fujiwara Y; Yoshinaga H; Maeda T; Mori Y; Nonaka K; Senoo K; Atsui F
    Nihon Naika Gakkai Zasshi; 1991 May; 80(5):766-7. PubMed ID: 1875114
    [No Abstract]   [Full Text] [Related]  

  • 24. Changes in granulocyte-monocyte colony-forming cells among leukocyte-interferon-treated chronic myelogenous leukemia patients.
    Talpaz M; Spitzer G; Hittelman W; Kantarjian H; Gutterman J
    Exp Hematol; 1986 Aug; 14(7):668-71. PubMed ID: 3460811
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Treatment of chronic myeloid leukemia using alpha-interferon and hydroxyurea. Study of 30 cases].
    Nese M; de Bellis R; Urtiarte R; Di Landro J
    Sangre (Barc); 1994 Jun; 39(3):183-6. PubMed ID: 7940047
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prior treatment with alpha-interferon does not adversely affect the outcome of allogeneic BMT in chronic phase chronic myeloid leukemia.
    Zuffa E; Bandini G; Bonini A; Santucci MA; Martinelli G; Rosti G; Testoni N; Zaccaria A; Tura S
    Haematologica; 1998 Mar; 83(3):231-6. PubMed ID: 9573677
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Concordant improvement of progressive systemic sclerosis and chronic myelogenous leukemia with interferon-alpha treatment].
    Watanabe S; Sugihara T; Takahashi M; Ata K; Kanzaki A; Yamada O; Yawata Y
    Rinsho Ketsueki; 1994 Sep; 35(9):895-7. PubMed ID: 7967060
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sustained cytogenetic response after discontinuation of imatinib mesylate in a patient with chronic myeloid leukaemia.
    Ghanima W; Kahrs J; Dahl TG; Tjonnfjord GE
    Eur J Haematol; 2004 Jun; 72(6):441-3. PubMed ID: 15128424
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [A case of chronic neutrophilic leukemia with abnormal karyotype].
    Kunishima S; Mizuno R; Fujishiro N; Ohno R
    Rinsho Byori; 1989 Aug; 37(8):943-7. PubMed ID: 2585758
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Reversible cardiomyopathy secondary to interferon-alpha in chronic myelogenous leukemia].
    Uehara E; Uesugi T; Tasaka T; Matsuhashi Y; Tamura T; Kuwajima M; Nagai M
    Gan To Kagaku Ryoho; 2002 Feb; 29(2):317-21. PubMed ID: 11865642
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Myeloid crisis of chronic myelogenous leukemia showing dramatic response to mithramycin and hydroxyurea combination].
    Ueki K; Tsuchida A; Murakami H; Karasawa M; Kobayashi N; Omine M; Naruse T
    Rinsho Ketsueki; 1989 Oct; 30(10):1840-2. PubMed ID: 2531808
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Autologous bone marrow or peripheral blood stem cell transplantation for patients with chronic myelogenous leukaemia in chronic phase.
    Meloni G; De Fabritiis P; Alimena G; Malagnino F; Montefusco E; Sandrelli A; Pinto R; Vignetti M; Lo Coco F; Mandelli F
    Bone Marrow Transplant; 1989 Dec; 4 Suppl 4():92-4. PubMed ID: 2576389
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Chronic myeloid leukemia associated with sustained severe pancytopenia after imatinib mesylate therapy].
    Sumi M; Tauchi T; Shimamoto T; Sshida G; Nakajima A; Ito Y; Ohyashiki K
    Rinsho Ketsueki; 2002 Sep; 43(9):868-70. PubMed ID: 12412295
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Agranulocytosis due to anti-tuberculosis drugs including isoniazid (INH) and rifampicin (RFP)--a report of four cases and review of the literature].
    Shishido Y; Nagayama N; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Komatsu H; Yotsumoto H
    Kekkaku; 2003 Nov; 78(11):683-9. PubMed ID: 14672045
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Hematologic response to low dose natural interferon-alpha in a case of CML with myelo-megakaryoblastic crisis].
    Nozaki H; Usui T; Yamauchi K; Kobayashi N; Nakamura Y; Watanabe K; Nagao T; Arimori S
    Rinsho Ketsueki; 1993 Feb; 34(2):232-4. PubMed ID: 8492424
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High-dose chemo-radiotherapy followed by autologous Philadelphia chromosome-negative blood progenitor cell transplantation in patients with chronic myelogenous leukemia.
    Carella AM; Chimirri F; PodestĂ  M; Pitto A; Piaggio G; Dejana A; Lerma E; Pollicardo N; Vassallo F; Soracco M; Benvenuto F; Valbonesi M; Carlier P; Vimercati R; Prencipe E; Gatti AM; Ferrara RA; Incagliato M; Florio G; Frassoni F
    Bone Marrow Transplant; 1996 Feb; 17(2):201-5. PubMed ID: 8640167
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High response rate using recombinant interferon-alpha in patients with newly diagnosed chronic myeloid leukemia.
    Mahon FX; Fabères C; Montastruc M; Si-Mour S; Boiron JM; Marit G; Bilhou-Nabera C; Cony-Makhoul P; Pigneux A; Bernard P; Broustet A; Reiffers J
    Bone Marrow Transplant; 1996 May; 17 Suppl 3():S33-7. PubMed ID: 8769698
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lymphoid blast crisis during interferon-alpha therapy in a patient with chronic myelogenous leukemia in myeloid blast crisis.
    Goto H; Tsurumi H; Hara T; Moriwaki H
    Int J Hematol; 2000 Dec; 72(4):474-6. PubMed ID: 11197215
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Successful low-dose etoposide therapy for a case of myelofibrosis with chronic myelogenous leukemia megakaryocytic predominance type].
    Katayama T; Masuoka H; Yoshida M; Watanabe R; Nishiwaki K; Shimada T; Kaito K; Ochiai S; Kobayashi M; Sakai O
    Rinsho Ketsueki; 1992 Apr; 33(4):488-93. PubMed ID: 1602613
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [A case of chronic myelogenous leukemia complicated with nephrotic syndrome].
    Yoshizaki N; Kohda K; Nakazawa O; Ando M; Miyazaki S; Takahashi M; Muramatsu H; Terada S; Kure T; Niitsu Y
    Rinsho Ketsueki; 1989 May; 30(5):691-6. PubMed ID: 2529382
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.